SCHEMBL6325972

SCHEMBL6325972

COC(F)(F)c1cccc(-c2noc(CCC(=O)O)n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 6/20 0.61
LMNA P02545 1/20 0.57
ATM Q13315 1/20 0.57
ALDH1A1 P00352 1/20 0.52
MITF O75030 1/20 0.52
TP53 P04637 1/20 0.52
NCOA3 Q9Y6Q9 1/20 0.52
TSHR P16473 3/20 0.51
HTT P42858 2/20 0.49
MAPK1 P28482 1/20 0.49
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
RXRG P48443 1/20 0.48
HPGD P15428 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325330 0.90 FFAR1 (0.50) FFAR1LMNAALDH1A1TP53TSHR
SCHEMBL6326394 0.86 LMNA (0.68) FFAR1LMNAATMALDH1A1MITF
SCHEMBL6324681 0.81 FFAR1 (0.75) FFAR1LMNAATMALDH1A1MITF
SCHEMBL6324430 0.79 MAPK1 (0.73) FFAR1LMNAATMALDH1A1TSHR
SCHEMBL6328269 0.78 FFAR1 (0.61) FFAR1LMNAATMALDH1A1MITF
SCHEMBL6326164 0.78 ALDH1A1 (0.63) FFAR1LMNAATMALDH1A1MITF
SCHEMBL19281404 0.78 TSHR (0.58) FFAR1LMNAATMALDH1A1MITF
SCHEMBL6326326 0.77 ALDH1A1 (0.59) FFAR1LMNAATMALDH1A1MITF
SCHEMBL5330405 0.77 ALDH1A1 (0.83) FFAR1LMNAATMALDH1A1MITF
SCHEMBL1544736 0.77 TSHR (0.71) FFAR1LMNAATMALDH1A1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423120-A4 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORP (US) 2005-12-28 EP disclosed
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed
EP-1423120-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2004-06-02 EP disclosed
US-20040087588-A1 Parp inhibitors ICOS CORPORATION 2004-05-06 US disclosed
WO-2003015785-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087588-A1 Parp inhibitors PARP1, PARP2, PARP11 FFAR1 2536/4885LMNA 448/4885ATM 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.